Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy is Caused by Local Production and Tubular Dysfunction

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Gerritsen, Karin G F ^a   Leeuwis, Jan Willem ^a   Koeners, Maarten P ^a   Bakker, Stephan J L ^b   Van Oeveren, Willem ^c   Aten, Jan ^d   Tarnow, Lise ^e   Rossing, Peter ^e   Wetzels, Jack F M ^f   Joles, Jaap A ^a   Kok, Robbert Jan ^g   Goldschmeding, Roel ^a   Nguyen, Tri Q ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c HaemoScan   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e STENO DIABETES CENTER   (Denmark)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; RECOMBINANT PROTEIN; BIOLOGICAL MARKER; CTGF PROTEIN, HUMAN; CTGF PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GLOMERULAR DYSFUNCTION; HISTOLOGY; HUMAN; IN SITU HYBRIDIZATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TUBULE ABSORPTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBULAR DYSFUNCTION; URINARY EXCRETION; ANIMAL; C57BL MOUSE; COHORT ANALYSIS; COMPLICATION; GENETICS; GLOMERULUS; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; UPREGULATION; URINE;

ADULT; ANIMALS; BIOMARKERS; COHORT STUDIES; CONNECTIVE TISSUE GROWTH FACTOR; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; KIDNEY TUBULES, PROXIMAL; MALE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; RENAL ELIMINATION; RENAL REABSORPTION; RNA, MESSENGER; UP-REGULATION;

EID: 84934344068     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/539787     Document Type: Article

References (47)

1. U. S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md, USA, 2013.
2. S. G. Adler, S.-W. Kang, S. Feld et al., "Glomerular mRNAS in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy", Kidney International, vol. 60, no. 6, pp. 2330-2336, 2001.
3. Y. Ito, J. Aten, R. J. Bende et al., "Expression of connective tissue growth factor in human renal fibrosis", Kidney International, vol. 53, no. 4, pp. 853-861, 1998.
4. R. M. Mason, "Connective tissue growth factor (CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?" Journal of Cell Communication and Signaling, vol. 3, no. 2, pp. 95-104, 2009.
5. T. Q. Nguyen, P. Roestenberg, F. A. Van Nieuwenhoven et al., "CTGF inhibits BMP-7 signaling in diabetic nephropathy", Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2098-2107, 2008.
6. T. Turk, J. W. Leeuwis, J. Gray et al., "BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression", Journal of Histochemistry and Cytochemistry, vol. 57, no. 7, pp. 623-631, 2009.
7. N. A. Wahab, L. Schaefer, B. S. Weston et al., "Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli", Diabetologia, vol. 48, no. 12, pp. 2650-2660, 2005.
8. L. R. James, C. Le, H. Doherty, H.-S. Kim, and N. Maeda, "Connective tissue growth factor (CTGF) expressionmodulates response to high glucose", PLoS ONE, vol. 8, no. 8, Article ID e70441, 2013.
9. S. G. Adler, S. Schwartz, M. E. Williams et al., "Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria", Clinical Journal of the American Society of Nephrology, vol. 5, no. 8, pp. 1420-1428, 2010.
10. H. Yokoi, M. Mukoyama, K. Mori et al., "Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice", Kidney International, vol. 73, no. 4, pp. 446-455, 2008.
11. M. Guha, Z.-G. Xu, D. Tung, L. Lanting, and R. Natarajan, "Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mousemodels of type 1 and type 2 diabetes", The FASEB Journal, vol. 21, no. 12, pp. 3355-3368, 2007.
12. S. Andersen, F. A. Van Nieuwenhoven, L. Tarnow et al., "Reduction of urinary connective tissue growth factor by Losartan in type 1 patientswith diabetic nephropathy", Kidney International, vol. 67, no. 6, pp. 2325-2329, 2005.
13. R. E. Gilbert, A. Akdeniz, S. Weitz et al., "Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy", Diabetes Care, vol. 26, no. 9, pp. 2632-2636, 2003.
14. T. Q. Nguyen, L. Tarnow, S. Andersen et al., "Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy", Diabetes Care, vol. 29, no. 1, pp. 83-88, 2006.
15. F. W. K. Tam, B. L. Riser, K. Meeran, J. Rambow, C. D. Pusey, and A. H. Frankel, "Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy", Cytokine, vol. 47, no. 1, pp. 37-42, 2009.
16. K. G. F. Gerritsen, H. P. Peters, T. Q. Nguyen et al., "Renal proximal tubular dysfunction is amajor determinant of urinary connective tissue growth factor excretion", The American Journal of Physiology-Renal Physiology, vol. 298, no. 6, pp. F1457-F1464, 2010.
17. A. A. Jaffa, W. R. Usinger, M. B. McHenry et al., "Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes", The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 5, pp. 1893-1900, 2008.
18. O. Miyazaki, S. Kurashita, I. Fukamachi, K. Endo, P.-S. Ng, and K. Takehara, "Subtraction method for determination of N-terminal connective tissue growth factor", Annals of Clinical Biochemistry, vol. 47, no. 3, pp. 205-211, 2010.
19. P. Roestenberg, F. A. Van Nieuwenhoven, L. Wieten et al., "Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy", Diabetes Care, vol. 27, no. 5, pp. 1164-1170, 2004.
20. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, "Amore accuratemethod toestimate glomerular filtration rate from serum creatinine: a new prediction equation", Annals of Internal Medicine, vol. 130, no. 6, pp. 461-470, 1999.
21. E. Meijer, W. E. Boertien, F. L. Nauta et al., "Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis", American Journal of Kidney Diseases, vol. 56, no. 5, pp. 883-895, 2010.
22. T. D. Lockwood and H. B. Bosmann, "The use of urinary N-acetyl-beta-glucosaminidase in human renal toxicology. I. Partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidney", Toxicology and Applied Pharmacology, vol. 49, no. 2, pp. 323-336, 1979.
23. Y. Ito, R. Goldschmeding, H. Kasuga et al., "Expression patterns of connective tissue growth factor and of TGF-β isoforms during glomerular injury recapitulate glomerulogenesis", American Journal of Physiology-Renal Physiology, vol. 299, no. 3, pp. F545-F558, 2010.
24. T method", Methods, vol. 25, no. 4, pp. 402-408, 2001.
25. M. T. Schram, N. Chaturvedi, C. G. Schalkwijk, J. H. Fuller, and C. D. A. Stehouwer, "Markers of inflammation are crosssectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes-the EURODIAB Prospective Complications Study", Diabetologia, vol. 48, no. 2, pp. 370-378, 2005.
26. P. Pietravalle, S. Morano, G. Cristina et al., "Charge selectivity of proteinuria in type I diabetes explored by Ig subclass clearance", Diabetes, vol. 40, no. 12, pp. 1685-1690, 1991.
27. J. Penders and J. R. Delanghe, "Alpha 1-microglobulin: clinical laboratory aspects and applications", Clinica Chimica Acta, vol. 346, no. 2, pp. 107-118, 2004.
28. M. A. G. J. Ten Dam, A. J. W. Branten, I. S. Klasen, and J. F. M. Wetzels, "The gelatin-derived plasma substitute gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption", Journal of Critical Care, vol. 16, no. 3, pp. 115-120, 2001.
29. F. Waanders, G. Navis, and H. Van Goor, "Urinary tubular biomarkers of kidney damage: potential value in clinical practice", The American Journal of Kidney Diseases, vol. 55, no. 5, pp. 813-816, 2010.
30. F. Waanders, M. M. Van Timmeren, C. A. Stegeman, S. J. L. Bakker, and H. Van Goor, "Kidney injury molecule-1 in renal disease", Journal of Pathology, vol. 220, no. 1, pp. 7-16, 2010.
31. J. M. Hofstra, J. K. J. Deegens, E. J. Steenbergen, and J. F. M. Wetzels, "Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy", Nephrology Dialysis Transplantation, vol. 23, no. 10, pp. 3160-3165, 2008.
32. R. G. H. J. Maatman, T. H. M. S. M. Van Kuppervelt, and J. H. Veerkamp, "Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization", Biochemical Journal, vol. 273, no. 3, pp. 759-766, 1991.
33. S. E. Thomson, S. V. McLennan, P. D. Kirwan et al., "Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy", Journal of Diabetes and Its Complications, vol. 22, no. 4, pp. 284-294, 2008.
34. S. Wang, M. De Nichilo, C. Brubaker, and R. Hirschberg, "Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy", Kidney International, vol. 60, no. 1, pp. 96-105, 2001.
35. T. Kobayashi, H. Okada, T. Inoue, Y. Kanno, and H. Suzuki, "Tubular expression of connective tissue growth factor correlates with interstitial fibrosis in type 2 diabetic nephropathy", Nephrology Dialysis Transplantation, vol. 21, no. 2, pp. 548-549, 2006.
36. R. E. Gilbert and M. E. Cooper, "The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?" Kidney International, vol. 56, no. 5, pp. 1627-1637, 1999.
37. C. J. Magri and S. Fava, "The role of tubular injury in diabetic nephropathy", European Journal of Internal Medicine, vol. 20, no. 6, pp. 551-555, 2009.
38. E. F. O. Kern, P. Erhard, W. Sun, S. Genuth, and M. F. Weiss, "Early urinarymarkers of diabetic kidney disease: a nested casecontrol study from the Diabetes Control and Complications Trial (DCCT)", American Journal of Kidney Diseases, vol. 55, no. 5, pp. 824-834, 2010.
39. S. E. Nielsen, T. Sugaya, P. Hovind, T. Baba, H.-H. Parving, and P. Rossing, "Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients", Diabetes Care, vol. 33, no. 6, pp. 1320-1324, 2010.
40. S. E. Nielsen, K. J. Schjoedt, A. S. Astrup et al., "Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril", Diabetic Medicine, vol. 27, no. 10, pp. 1144-1150, 2010.
41. S. E. Nielsen, T. Sugaya, L. Tarnow et al., "Tubular and glomerular injury in diabetes and the impact of ACE inhibition", Diabetes Care, vol. 32, no. 9, pp. 1684-1688, 2009.
42. N. A. Wahab, B. S. Weston, and R. M. Mason, "Modulation of the TGFβ/Smad signaling pathway in mesangial cells by CTGF/CCN2", Experimental Cell Research, vol. 307, no. 2, pp. 305-314, 2005.
43. Y.-C. Tay, Y. Wang, L. Kairaitis, G. K. Rangan, C. Zhang, and D. C. H. Harris, "Can murine diabetic nephropathy be separated from superimposed acute renal failure?" Kidney International, vol. 68, no. 1, pp. 391-398, 2005.
44. B. L. Riser, M. Denichilo, P. Cortes et al., "Regulation of connective tissue growth factor activity in cultured ratmesangial cells and its expression in experimental diabetic glomerulosclerosis", Journal of the American Society of Nephrology, vol. 11, no. 1, pp. 25-38, 2000.
45. S. M. Twigg, Z. Cao, S. V. McLennan et al., "Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine", Endocrinology, vol. 143, no. 12, pp. 4907-4915, 2002.
46. P. Roestenberg, F. A. Van Nieuwenhoven, J. A. Joles et al., "Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice", The American Journal of Physiology-Renal Physiology, vol. 290, no. 6, pp. F1344-F1354, 2006.
47. T. Q. Nguyen, L. Tarnow, A. Jorsal et al., "Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy", Diabetes Care, vol. 31, no. 6, pp. 1177-1182, 2008.